About Genome Medical
Genome Medical is a company based in Monterey (United States) founded in 2016.. Genome Medical has raised $172.98 million across 6 funding rounds from investors including Amgen, Kaiser Permanente and General Electric. The company has 84 employees as of December 31, 2023. Genome Medical has completed 1 acquisition, including GeneMatters. Genome Medical offers products and services including Genetic Counseling, Genetic Test Ordering, Clinical Trial Matching, and Peer-to-Peer Genetics Support. Genome Medical operates in a competitive market with competitors including Strand Life Sciences, Invitae, Myriad Genetics, Fulgent Genetics and AnchorDx, among others.
- Headquarter Monterey, United States
- Employees 84 as on 31 Dec, 2023
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Genome Medical, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$172.98 M (USD)
in 6 rounds
-
Latest Funding Round
$75.34 M (USD), Series D
Sep 10, 2024
-
Investors
Amgen
& 18 more
-
Employee Count
84
as on Dec 31, 2023
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Genome Medical
Genome Medical offers a comprehensive portfolio of products and services, including Genetic Counseling, Genetic Test Ordering, Clinical Trial Matching, and Peer-to-Peer Genetics Support. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Helps patients understand genetic risks and family health history.
Facilitates ordering and interpretation of genetic tests for diagnoses.
Matches patients to relevant clinical trials for rare conditions.
Offers expert advice and connections for genetics-related queries.
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Genome Medical
Genome Medical has successfully raised a total of $172.98M across 6 strategic funding rounds. The most recent funding activity was a Series D round of $75.34 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series D — $75.3M
-
First Round
First Round
(25 May 2017)
- Investors Count 19
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2024 | Amount | Series D - Genome Medical | Valuation |
investors |
|
| Aug, 2021 | Amount | Series C - Genome Medical | Valuation | Casdin Capital | |
| Jul, 2020 | Amount | Series B - Genome Medical | Valuation | Samsung Catalyst Fund |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Genome Medical
Genome Medical has secured backing from 19 investors, including venture fund and institutional investors. Prominent investors backing the company include Amgen, Kaiser Permanente and General Electric. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Founded Year | Domain | Location | |
|
Corporate backed venture capital fund investing in multiple sectors
|
Founded Year | Domain | Location | |
|
Health-tech companies are targeted for venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Genome Medical
Genome Medical has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include GeneMatters. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Telehealth-enabled genetic services for rare diseases are provided.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Genome Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Genome Medical Comparisons
Competitors of Genome Medical
Genome Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Strand Life Sciences, Invitae, Myriad Genetics, Fulgent Genetics and AnchorDx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| domain | founded_year | HQ Location |
Home-based genetic tests for detecting diseases are provided to individuals.
|
|
| domain | founded_year | HQ Location |
Molecular diagnostics and personalized medicine for cancer are developed.
|
|
| domain | founded_year | HQ Location |
Provider of genetic testing services for carrier screening cardiovascular diseases, epilepsy and cancer
|
|
| domain | founded_year | HQ Location |
High-throughput gene sequencing platform is developed for clinical diagnostics.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Genome Medical
Frequently Asked Questions about Genome Medical
When was Genome Medical founded?
Genome Medical was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Where is Genome Medical located?
Genome Medical is headquartered in Monterey, United States. It is registered at Monterey, California, United States.
Is Genome Medical a funded company?
Genome Medical is a funded company, having raised a total of $172.98M across 6 funding rounds to date. The company's 1st funding round was a Series B of $14.41M, raised on May 25, 2017.
How many employees does Genome Medical have?
As of Dec 31, 2023, the latest employee count at Genome Medical is 84.
What does Genome Medical do?
Genome Medical was founded in 2016 and is headquartered in Monterey, United States. Services in genomic testing are delivered to consumers and healthcare providers within the healthcare sector. Areas covered include reproductive genetics, cancer genetics, cardiovascular diseases, and pediatrics. Direct-to-consumer assessments for risks of various medical conditions are also facilitated through these operations.
Who are the top competitors of Genome Medical?
Genome Medical's top competitors include Strand Life Sciences, Fulgent Genetics and Centogene.
What products or services does Genome Medical offer?
Genome Medical offers Genetic Counseling, Genetic Test Ordering, Clinical Trial Matching, and Peer-to-Peer Genetics Support.
How many acquisitions has Genome Medical made?
Genome Medical has made 1 acquisition, including GeneMatters.
Who are Genome Medical's investors?
Genome Medical has 19 investors. Key investors include Amgen, Kaiser Permanente, General Electric, Canaan, and Revelation Partners.